DIASORIN SPA (DIA.MI) Stock Price, Quote, News and Overview
BIT:DIA - Borsa Italiana Milan - IT0003492391 - Common Stock - Currency: EUR
DIA.MI Quote, Performance and Key Statistics
DIASORIN SPA
BIT:DIA (2/5/2025, 9:35:12 AM)
102.075
-0.77 (-0.75%)
The current stock price of DIA.MI is 102.075 EUR. In the past month the price decreased by -0.1%. In the past year, price increased by 18.27%.
DIA.MI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 27.27 | 213.82B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 78.69 | 198.71B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 43.64 | 146.65B | ||
| 2M6.DE | MEDTRONIC PLC | 17.19 | 111.94B | ||
| BOX.DE | BECTON DICKINSON AND CO | 18.52 | 68.38B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 24.1 | 60.62B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 26.54 | 40.39B | ||
| DC4.DE | DEXCOM INC | 51.53 | 33.01B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 20.47 | 24.82B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 20.13 | 24.41B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 20.11 | 24.38B | ||
| BIM.PA | BIOMERIEUX | 33.7 | 13.80B |
Related stock screener links
About DIA.MI
Company Profile
DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. The company is headquartered in Saluggia, Vercelli and currently employs 3,233 full-time employees. The company went IPO on 2007-07-19. The firm specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The firm develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. The company operates through ELISA immunodiagnostic business portfolio.
Company Info
DIASORIN SPA
Via Crescentino Snc
Saluggia VERCELLI IT
Employees: 3186
Company Website: https://www.diasorin.com/
Investor Relations: https://diasoringroup.com/en/investors
Phone: 3901614871
DIA.MI FAQ
What is the stock price of DIA.MI?
The current stock price of DIA.MI is 102.075 EUR.
What is the symbol for DIASORIN SPA stock?
The exchange symbol of DIASORIN SPA is DIA and it is listed on the Borsa Italiana Milan exchange.
On which exchange is DIA.MI stock listed?
DIA.MI stock is listed on the Borsa Italiana Milan exchange.
Is DIA.MI a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for DIA.MI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of DIA.MI.
Does DIA.MI stock pay dividends?
DIA.MI has a dividend yield of 1.1%. The yearly dividend amount is currently 1.1.
What is the Price/Earnings (PE) ratio of DIA.MI?
The PE ratio for DIA.MI is 29.16. This is based on the reported non-GAAP earnings per share of 3.5 and the current share price of 102.075 EUR.
DIA.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to DIA.MI. When comparing the yearly performance of all stocks, DIA.MI turns out to be only a medium performer in the overall market: it outperformed 47.15% of all stocks.
DIA.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to DIA.MI. DIA.MI has an excellent financial health rating, but there are some minor concerns on its profitability.
DIA.MI Financial Highlights
Over the last trailing twelve months DIA.MI reported a non-GAAP Earnings per Share(EPS) of 3.5. The EPS decreased by -33.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.92% | ||
| ROA | 5.11% | ||
| ROE | 9.89% | ||
| Debt/Equity | 0.6 |
DIA.MI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 68% to DIA.MI. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of 24.89% and a revenue growth 3.71% for DIA.MI